These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 6519402)

  • 1. [Omeprazole: a new mechanism of action and an unprecedented efficacy in the treatment of gastric acid hypersecretion].
    Lewin MJ
    Gastroenterol Clin Biol; 1984 Dec; 8(12):939-42. PubMed ID: 6519402
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gastric secretory, ultrastructural and pH changes during prolonged treatment with omeprazole in a severe form of Zollinger-Ellison syndrome].
    Mignon M; Alcabes G; Lehy T; Nguyen Phuoc BK; Vatier J; Bonfils S
    Gastroenterol Clin Biol; 1984 Dec; 8(12):947-54. PubMed ID: 6519403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostaglandins and the gastric mucosa barrier].
    Molinari F; Parodi MC
    Recenti Prog Med; 1982 Oct; 73(4):363-7. PubMed ID: 7156464
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of the proton pump with omeprazole. A new principle of ulcer therapy?].
    Müller P; Dammann HG; Seitz H; Simon B
    MMW Munch Med Wochenschr; 1983 May; 125(21):459-60. PubMed ID: 6308432
    [No Abstract]   [Full Text] [Related]  

  • 5. Acid secretion by frog gastric mucosa is electroneutral.
    Hersey SJ; Sachs G; Kasbekar DK
    Am J Physiol; 1985 Feb; 248(2 Pt 1):G246-50. PubMed ID: 3970205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs.
    Konturek SJ; Cieszkowski M; Kwiecień N; Konturek J; Tasler J; Bilski J
    Gastroenterology; 1984 Jan; 86(1):71-7. PubMed ID: 6689674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transport processes in the gastric mucosa and their pharmacologic modification].
    Blum AL; Fimmel CJ
    Z Gastroenterol Verh; 1986 Apr; 21():124-8. PubMed ID: 2422828
    [No Abstract]   [Full Text] [Related]  

  • 8. [Omeprazole and inhibition of gastric acid secretion].
    Rossi G
    Recenti Prog Med; 1984 Apr; 75(4):419-21. PubMed ID: 6729204
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
    Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
    Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acid secretion and hormone levels after several weeks of omeprazole administration].
    Müller P; Simon B; Dammann HG; Feurle G; Huefner M; Rabe T
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1816. PubMed ID: 6641533
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of gastric acidity in horses.
    Murray MJ
    J Am Vet Med Assoc; 1997 Jul; 211(1):37-40. PubMed ID: 9215408
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of gastric hypersecretion in Zollinger-Ellison syndrome with omeprazole.
    Oberg K; Lindström H
    Lancet; 1983 Jan; 1(8314-5):66-7. PubMed ID: 6129395
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.
    Katashima M; Yamamoto K; Sugiura M; Sawada Y; Iga T
    Drug Metab Dispos; 1995 Jul; 23(7):718-23. PubMed ID: 7587960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel 2-[2-(substituted amino)phenethyl]-1 H-benzimidazoles; 3,4-dihydro and 1,2,3,4,-tetrahydropyrimido[1,6-a]-benzimidazoles as potential antiulcer agents.
    Shafik RM; El-Din SA; Eshba NH; El-Hawash SA; Desheesh MA; Abdel-Aty AS; Ashour HM
    Pharmazie; 2004 Dec; 59(12):899-905. PubMed ID: 15638075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hp and pH--the relevance of gastric acid to the treatment of Helicobacter pylori infection.
    Hunt RH
    J Gastroenterol; 1994 Jul; 29 Suppl 7():128-33. PubMed ID: 7921145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole has a dual mechanism of action: it inhibits both H(+)K(+)ATPase and gastric mucosa carbonic anhydrase enzyme in humans (in vitro and in vivo experiments).
    Puscas I; Coltau M; Baican M; Domuta G
    J Pharmacol Exp Ther; 1999 Aug; 290(2):530-4. PubMed ID: 10411559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease.
    Naesdal J; Bodemar G; Walan A
    Scand J Gastroenterol; 1984 Oct; 19(7):916-22. PubMed ID: 6531660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Omeprazole: effects and side effects].
    Hengels KJ
    Z Gastroenterol; 1984 May; 22(5):241-3. PubMed ID: 6741201
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastric mucosal function following withdrawal of omeprazole in rats.
    Noto T; Nagasaki M; Yomota E; Endo T
    Arzneimittelforschung; 1998 Jan; 48(1):70-3. PubMed ID: 9522036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ranitidine or nocloprost on the selected gastric juice components in the patients with the gastric ulcer.
    Skrodzka D; Gabryelewicz A
    Rocz Akad Med Bialymst; 1997; 42(1):257-66. PubMed ID: 9581490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.